Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Caribou Biosciences, Inc.
| Metric | Caribou Biosciences, Inc. CRBUHealthcare |
|---|---|
| Quality Score | 62 / 100 |
| Revenue (latest) | $11M |
| Net income (latest) | −$148M |
| Operating margin | −1329.4% |
| Net margin | −1327.4% |
| Return on equity | −121.2% |
| Return on assets | −84.5% |
| Return on capital (ROCE) | −98.9% |
| Debt / equity | 0.44× |
| Revenue growth (YoY) | 11.7% |
| Altman Z″ (distress) | -9.88 |
| Accruals / assets | −21.2% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.